Tinea corporis
Jump to navigation
Jump to search
Introduction
Ringworm of the body.
Epidemiology
- transmission is by direct skin to skin contact[4]
- person to person or animal to person
Pathology
- superficial skin infection, generally limited to epidermis
Clinical manifestations
- well-defined, scaly, macular eruption
- frequently forms annular lesions
- expands in a centrifugal pattern[4]
- erythematous border of small vesicles & scales
- may appear on any part of the body
- may be asymptomatic[4]
- pruritus is common[3]
- pruritic, peripheral annular, erythematous eruption with peripheral scaling, expanding outward as concentric rings[7]
- pain, tenderness, erosions generally do not occur[3]
- topical glucocorticoids may temporarily reduce inflammation & give the impression of improvement, but with rebound of symptoms with cessation of treatment[3]
* Images[5]
Laboratory
(see Tinea)
Differential diagnosis
- psoriasis
- nummular eczema
- usually occur on the lower extremities
- a scale or scaly eruption suggests Tinea corporis
- pityriasis rosea (herald patch)
- secondary syphilis
- erythema migrans (Lyme disease)
- axilla, inguinal region, popliteal fossa, belt line
- erythema migrans not associated with scale
Management
- topical imidazole compound for 2-3 weeks
- continue for 1 week after clinical cure
- clotrimazole# (Lotrimin)
- miconazole# (Monistat)
- ketoconazole (Nizoral)
- econazole (Spectazole)
- sulconazole (Exelderm)
- oxiconazole (Oxistat)
- terconazole (Terazol)
- butenafine* (Lotrimin Ultra)[2]
- oral antifungals
- extensive disease of lesions in beard
- griseofulvin (ultramicrosize) 250-375 mg BID for 4 weeks
- fluconazole 150 mg/week for 4 weeks
- itraconazole 100-400 mg/day for 2-20 weeks (mean 6.3 weeks)[6]
More general terms
References
- ↑ Stedman's Medical Dictionary 26th ed, Williams & Wilkins, Baltimore, 1995
- ↑ 2.0 2.1 Prescriber's Letter 9(2):11 2002
- ↑ 3.0 3.1 3.2 3.3 Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ 4.0 4.1 4.2 4.3 Grim L 12 Rashes You Need to Know: Common Dermatologic Diagnoses Medscape. Feb 10, 2021 https://reference.medscape.com/slideshow/skin-rashes-6004772
- ↑ 5.0 5.1 DermNet: Tinea corporis https://dermnetnz.org/topics/tinea-corporis
- ↑ 6.0 6.1 6.2 6.3 Khurana A, Agarwal A, Agrawal D et al Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris. A Randomized Clinical Trial. JAMA Dermatol. 2022;158(11):1269-1278. Sept 14. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36103158 PMCID: PMC9475442 (available on 2023-09-14) https://jamanetwork.com/journals/jamadermatology/fullarticle/2795924
- ↑ 7.0 7.1 NEJM Knowledge+ Dermatology